GlassScriptPhysician profile
Michael G Castello
NPI 1578728507
$839.03
in general payments reported to CMS, 2019-2025
13 companies · $69.39 in 2025
The $69.39 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $451 · 2020: $153 · 2021: $28.05 · 2023: $81.86 · 2024: $55.96 · 2025: $69.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $432.41 | 2019-2020 | |
| Calyxo, INC. | $69.39 | 2025 | Cvac Aspiration System |
| Karl Storz Endoscopy-America | $66.42 | 2019 | |
| Boston Scientific Corporation | $65.47 | 2021-2023 | Lithovue Empower |
| Teleflex LLC | $40.95 | 2021-2024 | Urolift |
| Astellas Pharma US INC | $29.49 | 2020 | |
| Laborie Medical Technologies Corp. | $25.73 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $22.28 | 2020 | |
| Rochester Medical Corporation | $18.79 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.04 | 2019 | |
| Sumitomo Pharma America, INC. | $17.01 | 2024 | Orgovyx |
| Endo Pharmaceuticals INC. | $16.71 | 2023 | Xiaflex, Aveed |
| Tolmar Pharmaceuticals, INC. | $16.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Castello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.